Predicting treatment response in major depressive disorder: the impact of early symptomatic improvement.
about
Treatment-resistant depression in primary care across CanadaThe International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.Early Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder.Forbearance for fluoxetine: do monoaminergic antidepressants require a number of years to reach maximum therapeutic effect in humans?Treating to target in major depressive disorder: response to remission to functional recovery.
P2860
Predicting treatment response in major depressive disorder: the impact of early symptomatic improvement.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Predicting treatment response ...... early symptomatic improvement.
@en
type
label
Predicting treatment response ...... early symptomatic improvement.
@en
prefLabel
Predicting treatment response ...... early symptomatic improvement.
@en
P2860
P1476
Predicting treatment response ...... early symptomatic improvement
@en
P2093
Danielle S Cha
Roger S McIntyre
P2860
P304
P356
10.1177/070674371205701211
P407
P50
P577
2012-12-01T00:00:00Z